Show Me the Money: Where Is Venture Capital Placing Bets in Bio-based?

From 2010 to 2015, the bio-based materials and chemicals (BBMC) industry attracted nearly $9.2 billion in funding from corporates, debts, individuals, private equity, public investment, and venture capital (VC). Notably, VCs have been the major financing driver for start-ups and invested $5.3 billio...

This item has been archived in line with our efforts to keep our content relevant and up to date for our readership. For further assistance, please contact your Customer Success Manager or email ClientEngagementTeam@luxresearchinc.com. Thank you!

Related Research

Ginkgo Bioworks to go public via $17.5 billion SPAC deal

News Commentary | May 13, 2021

Backed by Harry Sloan and Jeff Sagansky, this merger with Soaring Eagle Acquisition will give Ginkgo a pre‑money equity valuation of $15 billion, with an additional $2.5 billion for the combined entity – one of the biggest SPAC deals in recent times. This news comes on the heels of Zymergen's IPO ... To read more, click here.

Amyris partners with Ingredion to bring its Reb M sweetener to B2B market

News Commentary | May 13, 2021

With an estimated transaction value of $100 million, Ingredion will get exclusive license to sell and market Amyris' Reb M sweetener technology under this agreement. Additionally, Ingredion will also get a minority stake in Amyris' new production facility in Brazil, to be completed by Q4 2021. ... Not part of subscription

Funding momentum for cell-based meat continues as Aleph Farms raises $105 million Series B

News Commentary | July 08, 2021

L Catterton and DisruptAD, the venture capital arm of ADQ, led this Series B round, with participation from other corporate strategic investors like Thai Union Group, Cargill, and CJ CheilJedang, among others. Aleph Farms will use this funding to scale up cell‑based beef steak production and to ... Not part of subscription